Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

Atualização das recomendações da Sociedade Portuguesa de Cuidados Intensivos e do Grupo de Infeção e Sépsis para a abordagem da COVID-19 em Medicina Intensiva.

Publisher: Associação de Medicina Intensiva Brasileira Country of Publication: Brazil NLM ID: 9506692 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1982-4335 (Electronic) Linking ISSN: 0103507X NLM ISO Abbreviation: Rev Bras Ter Intensiva Subsets: MEDLINE

Original Publication: [Rio de Janeiro] : Associação de Medicina Intensiva Brasileira,

COVID-19* ; Sepsis*/therapy; Critical Care ; Humans ; Intensive Care Units ; SARS-CoV-2

Introduction: The Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group have previously issued health service and management recommendations for critically ill patients with COVID-19. Due to the evolution of knowledge, the panel of experts was again convened to review the current evidence and issue updated recommendations.
Methods: A national panel of experts who declared that they had no conflicts of interest regarding the development of the recommendations was assembled. Operational questions were developed based on the PICO methodology, and a rapid systematic review was conducted by consulting different bibliographic sources. The panel determined the direction and strength of the recommendations using two Delphi rounds, conducted in accordance with the principles of the GRADE system. A strong recommendation received the wording "is recommended", and a weak recommendation was written as "is suggested."
Results: A total of 48 recommendations and 30 suggestions were issued, covering the following topics: diagnosis of SARS-CoV-2 infection, coinfection and superinfection; criteria for admission, cure and suspension of isolation; organization of services; personal protective equipment; and respiratory support and other specific therapies (antivirals, immunomodulators and anticoagulation).
Conclusion: These recommendations, specifically oriented to the Portuguese reality but that may also apply to Portuguese-speaking African countries and East Timor, aim to support health professionals in the management of critically ill patients with COVID-19. They will be continuously reviewed to reflect the progress of our understanding and the treatment of this pathology.

JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533)
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1487-1495. (PMID: 31454263)
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188. (PMID: 32164085)
Lancet. 2020 Feb 15;395(10223):514-523. (PMID: 31986261)
J Thromb Haemost. 2020 Jun;18(6):1517-1519. (PMID: 32294295)
J Clin Invest. 2020 May 1;130(5):2620-2629. (PMID: 32217835)
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. (PMID: 32228035)
J Hosp Infect. 2021 Apr;110:103-107. (PMID: 33484783)
N Engl J Med. 2021 Apr 22;384(16):1491-1502. (PMID: 33631065)
Intensive Care Med. 2012 Oct;38(10):1647-53. (PMID: 22777516)
Hong Kong Med J. 2003 Dec;9(6):399-406. (PMID: 14660806)
Clin Microbiol Infect. 2021 Aug;27(8):1124-1130. (PMID: 33813110)
Lancet Respir Med. 2020 Apr;8(4):e24. (PMID: 32178774)
N Engl J Med. 2014 Apr 24;370(17):1583-93. (PMID: 24635770)
Euro Surveill. 2021 Aug;26(33):. (PMID: 34414882)
N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530)
Intensive Care Med. 2020 Nov;46(11):2094-2095. (PMID: 32737522)
N Engl J Med. 2021 Feb 11;384(6):497-511. (PMID: 33264556)
BMJ. 2020 May 14;369:m1849. (PMID: 32409561)
N Engl J Med. 2020 Aug 6;383(6):590-592. (PMID: 32402155)
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. (PMID: 32199469)
N Engl J Med. 2020 May 7;382(19):1787-1799. (PMID: 32187464)
Int J Infect Dis. 2021 Feb;103:62-71. (PMID: 33212256)
Intensive Care Med. 2018 Jul;44(7):1003-1016. (PMID: 29761216)
Lancet Respir Med. 2021 Mar;9(3):295-304. (PMID: 33493450)
N Engl J Med. 2000 May 4;342(18):1301-8. (PMID: 10793162)
N Engl J Med. 2013 Jun 6;368(23):2159-68. (PMID: 23688302)
Clin Vaccine Immunol. 2016 Jul 05;23(7):540-5. (PMID: 27193039)
Lancet Haematol. 2016 Jan;3(1):e45-52. (PMID: 26765648)
Ann Transl Med. 2017 Dec;5(Suppl 4):S37. (PMID: 29302593)
Rev Bras Ter Intensiva. 2020 Mar;32(1):2-10. (PMID: 32401989)
Chest. 2001 Dec;120(6 Suppl):375S-95S. (PMID: 11742959)
Intensive Care Med. 2020 May;46(5):854-887. (PMID: 32222812)
Crit Care. 2021 Feb 18;25(1):72. (PMID: 33602296)
Signal Transduct Target Ther. 2021 Feb 10;6(1):58. (PMID: 33568628)
Am J Trop Med Hyg. 2020 Oct;103(4):1635-1639. (PMID: 32828135)
Stem Cells Transl Med. 2021 May;10(5):660-673. (PMID: 33400390)
Am J Health Syst Pharm. 2020 Oct 14;77(21):1739-1745. (PMID: 32628248)
Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6. (PMID: 32471783)
Ann Intern Med. 2020 Sep 15;173(6):W122. (PMID: 32735446)
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. (PMID: 32391667)
Clin Med (Lond). 2021 Jan;21(1):e71-e76. (PMID: 33355197)
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. (PMID: 32215952)
JAMA. 2016 Feb 23;315(8):801-10. (PMID: 26903338)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Ann Intensive Care. 2020 Mar 30;10(1):37. (PMID: 32232685)
JAMA. 2020 Dec 1;324(21):2165-2176. (PMID: 33165621)
Br J Anaesth. 2021 Jan;126(1):e44-e46. (PMID: 33138964)
Ann Am Thorac Soc. 2021 Oct;18(10):1685-1692. (PMID: 33617747)
Crit Care Med. 2021 Mar 1;49(3):e219-e234. (PMID: 33555780)
JAMA. 2021 May 4;325(17):1731-1743. (PMID: 33764378)
Cell Res. 2020 Mar;30(3):269-271. (PMID: 32020029)
J Thromb Haemost. 2020 May;18(5):1020-1022. (PMID: 32239799)
Ann Am Thorac Soc. 2017 Oct;14(Supplement_4):S271-S279. (PMID: 28846440)
Cochrane Database Syst Rev. 2020 May 14;5:CD013600. (PMID: 32406927)
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. (PMID: 32719848)
Anaesthesia. 2020 Dec;75(12):1691-1692. (PMID: 32525226)
Cochrane Database Syst Rev. 2016 Jun 27;(6):CD002787. (PMID: 27347773)
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. (PMID: 32298251)
Clin Infect Dis. 2020 Jul 28;71(15):732-739. (PMID: 32150618)
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201. (PMID: 33217246)
Crit Care. 2020 Apr 15;24(1):148. (PMID: 32293518)
BMJ. 2008 Apr 26;336(7650):924-6. (PMID: 18436948)
Ann Intern Med. 2020 Oct 20;173(8):623-631. (PMID: 32673060)
Blood Transfus. 2020 May;18(3):167-169. (PMID: 32281926)
JAMA. 2020 May 26;323(20):2089-2090. (PMID: 32320008)
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents. (PMID: 11585785)
Lancet. 2020 May 2;395(10234):1417-1418. (PMID: 32325026)
Lancet. 2021 May 01;397(10285):1637-1645. (PMID: 33933206)
Infect Control Hosp Epidemiol. 1994 Feb;15(2):70-1. (PMID: 8201235)
JAMA Intern Med. 2021 Jan 1;181(1):24-31. (PMID: 33080005)
Lancet. 2018 Apr 28;391(10131):1693-1705. (PMID: 29726345)
Crit Care. 2021 Mar 25;25(1):121. (PMID: 33766109)
JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003)
Chest. 2017 Sep;152(3):639-649. (PMID: 28642106)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Sci Rep. 2020 Dec 4;10(1):21291. (PMID: 33277573)
Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135. (PMID: 32396381)
Front Med (Lausanne). 2020 Dec 23;7:614152. (PMID: 33425957)
Clin Infect Dis. 2020 Jul 28;71(15):762-768. (PMID: 32161940)
Science. 2020 Oct 23;370(6515):. (PMID: 32972995)
Biosci Trends. 2020 Mar 16;14(1):72-73. (PMID: 32074550)
N Engl J Med. 2004 Jul 22;351(4):327-36. (PMID: 15269312)
Cureus. 2020 Jun 3;12(6):e8429. (PMID: 32642345)
BMJ Open Respir Res. 2020 Jul;7(1):. (PMID: 32624494)
Lancet. 2020 May 16;395(10236):1569-1578. (PMID: 32423584)
Sci Rep. 2017 Mar 06;7:43395. (PMID: 28262699)
Cochrane Database Syst Rev. 2017 Jul 13;7:CD004104. (PMID: 28702957)
Cell Death Dis. 2016 Jan 21;7:e2062. (PMID: 26794657)
Lancet Respir Med. 2021 Feb;9(2):e16-e17. (PMID: 33428874)
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. (PMID: 32602883)
N Engl J Med. 2020 May 28;382(22):2158-2160. (PMID: 32329972)
JAMA. 2020 Oct 6;324(13):1307-1316. (PMID: 32876695)
Travel Med Infect Dis. 2020 Mar - Apr;34:101623. (PMID: 32179124)
Am J Cardiol. 2006 Apr 17;97(8A):77C-81C. (PMID: 16581333)
BMJ. 2020 Mar 26;368:m1256. (PMID: 32217555)
Cell. 2020 Jul 23;182(2):429-446.e14. (PMID: 32526206)
Crit Care Med. 2017 Dec;45(12):2078-2088. (PMID: 28938253)
Cochrane Database Syst Rev. 2018 Aug 03;8:CD000567. (PMID: 30073665)
Thorax. 2004 Mar;59(3):252-6. (PMID: 14985565)
Eur Respir J. 2019 Apr 11;53(4):. (PMID: 30705129)
Clin Infect Dis. 2018 Aug 31;67(6):e1-e94. (PMID: 29955859)
Heart. 2020 Oct;106(19):1519-1524. (PMID: 32611676)
Lancet Respir Med. 2020 May;8(5):518-526. (PMID: 32203711)
N Engl J Med. 2020 Nov 5;383(19):1827-1837. (PMID: 32459919)
JAMA. 2020 Oct 6;324(13):1317-1329. (PMID: 32876697)
J Clin Med. 2020 Sep 02;9(9):. (PMID: 32887462)
JAMA. 2020 Oct 6;324(13):1330-1341. (PMID: 32876694)
JAMA. 2021 Feb 16;325(7):632-644. (PMID: 33475701)
JAMA. 2020 Aug 25;324(8):799-801. (PMID: 32702090)
Respirology. 2020 Dec;25(12):1316-1319. (PMID: 33140491)
Risk Anal. 2020 May;40(5):902-907. (PMID: 32356927)
J Clin Pharm Ther. 2020 Dec;45(6):1244-1252. (PMID: 32767823)
Intensive Care Med. 2020 Jun;46(6):1099-1102. (PMID: 32291463)
JAMA. 2008 Feb 13;299(6):646-55. (PMID: 18270353)
Kidney Int. 2020 May;97(5):829-838. (PMID: 32247631)
Intensive Care Med. 2017 Feb;43(2):192-199. (PMID: 27812731)
MMWR Morb Mortal Wkly Rep. 2021 Feb 19;70(7):254-257. (PMID: 33600386)
Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241. (PMID: 32671131)
J Clin Med. 2020 Jul 27;9(8):. (PMID: 32726951)
Blood. 2020 Jun 4;135(23):2033-2040. (PMID: 32339221)
CADTH Technol Overv. 2013;3(1):e3201. (PMID: 23463843)
Crit Care. 2020 Mar 24;24(1):104. (PMID: 32204710)
Lancet. 2020 Feb 29;395(10225):689-697. (PMID: 32014114)
Thyroid. 2021 Jan;31(1):8-11. (PMID: 32600165)
Nephron Clin Pract. 2012;120(4):c179-84. (PMID: 22890468)
Lancet Respir Med. 2020 Apr;8(4):e19. (PMID: 32105633)
TH Open. 2020 Jun 26;4(2):e138-e144. (PMID: 32607467)
Med. 2020 Dec 18;1(1):114-127.e3. (PMID: 32838355)
J Thromb Haemost. 2020 May;18(5):1023-1026. (PMID: 32338827)
Crit Care. 2020 Apr 22;24(1):165. (PMID: 32321562)
J Hosp Infect. 2020 Mar;104(3):246-251. (PMID: 32035997)
ASAIO J. 2020 Jun;66(6):588-598. (PMID: 32358232)
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901. (PMID: 25695688)
Acta Anaesthesiol Scand. 2018 Apr;62(4):420-450. (PMID: 29479665)
N Engl J Med. 2021 May 13;384(19):1866-1868. (PMID: 33761203)
Crit Care. 2020 Jun 5;24(1):299. (PMID: 32503617)
Curr Atheroscler Rep. 2020 Aug 24;22(10):61. (PMID: 32830286)
Infect Control. 1986 Aug;7(8):403-7. (PMID: 3091523)
N Engl J Med. 1990 Nov 22;323(21):1451-7. (PMID: 2233917)
Nat Commun. 2020 Oct 20;11(1):5284. (PMID: 33082342)
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386. (PMID: 32240123)
N Engl J Med. 2021 Mar 4;384(9):795-807. (PMID: 33306283)
Intensive Care Med. 2020 Jun;46(6):1089-1098. (PMID: 32367170)
N Engl J Med. 2020 Nov 19;383(21):2030-2040. (PMID: 33031652)
Crit Care Explor. 2021 Jan 22;3(1):e0329. (PMID: 33521646)
JAMA. 2020 May 26;323(20):2085-2086. (PMID: 32293646)
Medicine (Baltimore). 2019 Feb;98(8):e14453. (PMID: 30813144)
JAMA. 2019 Feb 19;321(7):654-664. (PMID: 30772908)
Infect Dis Ther. 2020 Dec;9(4):823-836. (PMID: 32880102)
Ann Intensive Care. 2018 May 22;8(1):66. (PMID: 29789983)
J Transl Med. 2011 Mar 22;9:29. (PMID: 21418664)
N Engl J Med. 2020 Dec 10;383(24):2333-2344. (PMID: 33085857)
JAMA Cardiol. 2020 Jul 1;5(7):802-810. (PMID: 32211816)
Eur J Pharm Sci. 2021 Feb 1;157:105631. (PMID: 33115675)
Chest. 2014 Oct;146(4 Suppl):e61S-74S. (PMID: 25144591)
Crit Care. 2021 Feb 24;25(1):81. (PMID: 33627160)
Int J Infect Dis. 2020 May;94:119-124. (PMID: 32247050)
Acad Emerg Med. 2020 May;27(5):375-378. (PMID: 32320506)
Eur Heart J. 2018 May 14;39(19):1672-1686f. (PMID: 29509886)
Lancet Rheumatol. 2020 Jul;2(7):e393-e400. (PMID: 32835245)
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. (PMID: 32405603)
Antiviral Res. 2020 Jun;178:104787. (PMID: 32251768)
Lancet Respir Med. 2020 Mar;8(3):267-276. (PMID: 32043986)
PLoS One. 2011;6(6):e20476. (PMID: 21694759)
N Engl J Med. 2020 Jul 16;383(3):240-251. (PMID: 32668114)
BMJ. 2021 Feb 3;372:n208. (PMID: 33536228)
N Engl J Med. 2020 May 21;382(21):e70. (PMID: 32374956)
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. (PMID: 30576221)
JAMA. 2017 Oct 10;318(14):1335-1345. (PMID: 28973363)
N Engl J Med. 2021 Jan 21;384(3):238-251. (PMID: 33332778)
J Crit Care. 2021 Feb;61:63-70. (PMID: 33096347)
Crit Care. 2020 Jul 29;24(1):469. (PMID: 32727526)
Eur Respir J. 2020 Oct 15;56(4):. (PMID: 32747395)
JAMA. 2012 Jun 20;307(23):2526-33. (PMID: 22797452)
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415. (PMID: 32467113)
JACC Cardiovasc Imaging. 2020 Nov;13(11):2457-2459. (PMID: 32713771)
JAMA Netw Open. 2020 Jun 1;3(6):e2013136. (PMID: 32579195)
Lancet Microbe. 2021 Aug;2(8):e354-e365. (PMID: 34100002)
Cochrane Database Syst Rev. 2019 Jul 23;7:CD004477. (PMID: 31334568)
JAMA. 2009 Nov 4;302(17):1865-71. (PMID: 19797474)
Clin Infect Dis. 2021 Dec 6;73(11):e4073-e4081. (PMID: 32674126)
Lancet. 2020 May 9;395(10235):1516. (PMID: 32334650)
Crit Care Med. 2021 Feb 1;49(2):261-270. (PMID: 33201005)
Natl Sci Rev. 2020 Jun;7(6):1012-1023. (PMID: 34676127)
Pulmonology. 2021 Jul-Aug;27(4):305-312. (PMID: 33516668)
Ann Intensive Care. 2020 Jun 17;10(1):84. (PMID: 32556826)
Clin Infect Dis. 2021 Aug 2;73(3):531-534. (PMID: 32770240)
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. (PMID: 32350134)
Cochrane Database Syst Rev. 2016 Mar 07;3:CD010406. (PMID: 26950335)
Cochrane Database Syst Rev. 2016 Feb 15;2:CD003709. (PMID: 26878401)
Front Pharmacol. 2018 Nov 06;9:1157. (PMID: 30459597)
Clin Ethics. 2017 Sep;12(3):150-165. (PMID: 28989327)
Chest. 2020 Sep;158(3):1143-1163. (PMID: 32502594)
Chest. 2020 Nov;158(5):1992-2002. (PMID: 32681847)
J Evid Based Med. 2020 May;13(2):93-101. (PMID: 32167245)
J Infect. 2020 Jul;81(1):147-178. (PMID: 32283153)
JAMA. 2020 Jul 7;324(1):57-67. (PMID: 32496521)
JAMA. 2021 Apr 13;325(14):1426-1435. (PMID: 33662102)
Br J Anaesth. 2020 May;124(5):497-501. (PMID: 32115186)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Ann Intern Med. 2020 Nov 3;173(9):W147-W148. (PMID: 32956599)
Intensive Care Med. 2021 Feb;47(2):188-198. (PMID: 33388794)
Crit Care. 2020 Jan 30;24(1):28. (PMID: 32000806)
Lancet Respir Med. 2020 Aug;8(8):752-754. (PMID: 32598907)
N Engl J Med. 2010 Sep 16;363(12):1107-16. (PMID: 20843245)
Lancet. 2020 Feb 15;395(10223):473-475. (PMID: 32043983)
Ann Intensive Care. 2019 Jun 13;9(1):69. (PMID: 31197492)
JAMA. 2019 Jun 11;321(22):2175-2182. (PMID: 31184740)
Clin Infect Dis. 2021 May 4;72(9):e373-e381. (PMID: 32785710)
Nat Med. 2020 May;26(5):672-675. (PMID: 32296168)
Ann Intensive Care. 2020 Mar 18;10(1):33. (PMID: 32189136)
Eur Respir J. 2019 Oct 9;54(3):. (PMID: 31473594)
J Thromb Thrombolysis. 2020 Jul;50(1):72-81. (PMID: 32440883)
Lancet. 2020 Jun 6;395(10239):1763-1770. (PMID: 32442528)
J Thromb Haemost. 2020 Aug;18(8):1859-1865. (PMID: 32459046)
Kidney Int. 2020 Jul;98(1):209-218. (PMID: 32416116)
Circulation. 2020 May 19;141(20):1648-1655. (PMID: 32200663)
EMBO Mol Med. 2020 Jul 7;12(7):e12421. (PMID: 32428990)
Open Forum Infect Dis. 2020 Sep 23;7(10):ofaa446. (PMID: 33134417)
Intensive Care Med. 2019 May;45(5):563-572. (PMID: 30888444)
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. (PMID: 32311448)
Am J Cardiol. 2020 Oct 1;132:147-149. (PMID: 32762961)
N Engl J Med. 2015 Feb 19;372(8):747-55. (PMID: 25693014)
BMJ. 2020 Oct 22;371:m3939. (PMID: 33093056)
JAMA. 2016 Sep 27;316(12):1298-309. (PMID: 27673307)
Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442. (PMID: 27626833)
JAMA. 2020 Aug 4;324(5):460-470. (PMID: 32492084)
J Thromb Haemost. 2020 May;18(5):1094-1099. (PMID: 32220112)
Can J Anaesth. 2020 May;67(5):568-576. (PMID: 32052373)
Lancet. 2020 Oct 24;396(10259):1345-1352. (PMID: 33031764)
N Engl J Med. 2015 Jun 4;372(23):2185-96. (PMID: 25981908)
Radiology. 2020 Aug;296(2):E32-E40. (PMID: 32101510)
Am J Respir Crit Care Med. 2020 Jan 15;201(2):178-187. (PMID: 31577153)
Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579)
Stem Cell Res Ther. 2020 Aug 18;11(1):361. (PMID: 32811531)
JAMA. 2020 Oct 6;324(13):1298-1306. (PMID: 32876689)
BMJ. 2020 Mar 17;368:m1086. (PMID: 32184201)
J Card Fail. 2020 May;26(5):370. (PMID: 32439095)
JAMA. 2008 Feb 13;299(6):637-45. (PMID: 18270352)
JAMA Intern Med. 2020 Jul 1;180(7):934-943. (PMID: 32167524)
Pulmonology. 2021 Jan-Feb;27(1):52-66. (PMID: 32713784)
N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409)
Chest. 2020 Mar;157(3):566-573. (PMID: 31589844)
Intensive Care Med. 2020 Jun;46(6):1124-1126. (PMID: 32328726)
N Engl J Med. 2021 Mar 11;384(10):905-914. (PMID: 33356051)
Nat Commun. 2021 Apr 15;12(1):2349. (PMID: 33859192)
Am J Respir Crit Care Med. 2020 Jan 1;201(1):20-32. (PMID: 31437406)
RMD Open. 2021 Feb;7(1):. (PMID: 33542047)
PLoS One. 2020 Dec 2;15(12):e0242763. (PMID: 33264337)
Clin Appl Thromb Hemost. 2010 Oct;16(5):584-90. (PMID: 19850587)
Crit Care Med. 2009 Jun;37(6):1921-8. (PMID: 19384209)
Sci Rep. 2021 May 11;11(1):9927. (PMID: 33976287)
Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578)
N Engl J Med. 2020 Nov 5;383(19):1813-1826. (PMID: 32445440)
J Heart Lung Transplant. 2020 May;39(5):405-407. (PMID: 32362390)
N Engl J Med. 2021 Feb 18;384(7):619-629. (PMID: 33232588)
Gastroenterology. 2020 Jul;159(1):373-375.e2. (PMID: 32294477)
J Clin Med. 2020 Jul 24;9(8):. (PMID: 32722159)
JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775)
Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651)
Chest. 2015 May;147(5):1336-1343. (PMID: 25392954)
Crit Care Explor. 2020 Dec 16;2(12):e0309. (PMID: 33354679)
N Engl J Med. 2020 Nov 19;383(21):2041-2052. (PMID: 32706953)
Cochrane Database Syst Rev. 2013 May 31;(5):CD005351. (PMID: 23728654)
Crit Care Med. 2017 Sep;45(9):1538-1545. (PMID: 28817481)
JAMA. 2020 Dec 8;324(22):2251-2252. (PMID: 33206133)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
Crit Care. 2020 May 18;24(1):237. (PMID: 32423452)
Crit Care Med. 2016 Feb;44(2):282-90. (PMID: 26584191)
N Engl J Med. 2021 Feb 18;384(7):610-618. (PMID: 33406353)
Intensive Care Med. 2020 Apr;46(4):579-582. (PMID: 32103284)
Crit Care Med. 2016 Jan;44(1):188-201. (PMID: 26509317)
Lancet Respir Med. 2021 Feb;9(2):196-206. (PMID: 33189161)
ASAIO J. 2021 May 1;67(5):485-495. (PMID: 33657573)
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. (PMID: 29161116)
Nat Med. 2020 May;26(5):681-687. (PMID: 32327758)
N Engl J Med. 2021 May 20;384(20):1885-1898. (PMID: 33725432)
Lancet. 2018 Jul 7;392(10141):31-40. (PMID: 29910040)
PLoS One. 2012;7(10):e47559. (PMID: 23133515)
N Engl J Med. 2021 Apr 22;384(16):1503-1516. (PMID: 33631066)
N Engl J Med. 2021 Jan 7;384(1):20-30. (PMID: 33332779)
Crit Care Med. 2017 Mar;45(3):486-552. (PMID: 28098591)
Curr Opin Infect Dis. 2019 Apr;32(2):176-186. (PMID: 30724789)
Ann Intensive Care. 2021 Jan 29;11(1):20. (PMID: 33512602)
Lancet. 2020 Feb 15;395(10223):469-470. (PMID: 31986258)
Thromb Res. 2020 Aug;192:152-160. (PMID: 32485418)
Nature. 2020 Sep;585(7824):273-276. (PMID: 32516797)
Int J Antimicrob Agents. 2020 Jul;56(1):105949. (PMID: 32205204)
EClinicalMedicine. 2020 Nov;28:100570. (PMID: 33043285)
Intensive Care Med. 2012 May;38(5):796-803. (PMID: 22476448)
Crit Care. 2013 Apr 19;17(2):R75. (PMID: 23601744)
JAMA Neurol. 2020 Jun 1;77(6):683-690. (PMID: 32275288)
Lancet Rheumatol. 2020 Jun;2(6):e325-e331. (PMID: 32501454)
Antimicrob Agents Chemother. 2020 Aug 20;64(9):. (PMID: 32661006)

Local Abstract: [Publisher, Portuguese] A Sociedade Portuguesa de Cuidados Intensivos e o Grupo de Infeção e Sépsis emitiram previamente recomendações visando à organização dos serviços de saúde e ao manejo dos doentes críticos com COVID-19. Em virtude da evolução do conhecimento, o painel de peritos voltou a se organizar para rever a atual evidência e emitir recomendações atualizadas. [Publisher, Portuguese] Foi reunido um painel nacional de peritos que declararam não ter conflitos de interesse para o desenvolvimento das recomendações. Foram desenvolvidas perguntas operacionais conforme a metodologia PICO, e foi conduzida uma revisão sistemática rápida por meio da consulta de diferentes fontes bibliográficas. O painel determinou a direção e a força das recomendações com a utilização de duas rodadas de um método Delphi, conduzido seguindo princípios do sistema GRADE. Uma recomendação forte recebeu a redação “recomenda-se”, e uma recomendação fraca foi redigida como “sugere-se”. [Publisher, Portuguese] Foram emitidas 48 recomendações e 30 sugestões abrangendo os seguintes tópicos: diagnóstico de infecção por SARS-CoV-2, coinfecção e superinfecção; critérios de admissão, cura e suspensão de isolamento; organização dos serviços; Equipamentos de Proteção Individual; terapêuticas de suporte respiratório e outras e terapêuticas específicas (antivirais, imunomodeladores e anticoagulação). [Publisher, Portuguese] Essas recomendações, especificamente orientadas para a realidade portuguesa, mas que podem se aplicar também aos Países Africanos de Língua Oficial Portuguesa e ao Timor-Leste, visam apoiar os profissionais de saúde no manejo de doentes críticos com COVID-19. Pretende-se que sejam constantemente revistas, de modo a refletir o avanço de nossa compreensão e o da terapêutica dessa patologia.

Date Created: 20220126 Date Completed: 20220128 Latest Revision: 20240824

20250114

PMC8889599

10.5935/0103-507X.0103-507X-rbti-20210080

35081236